ARTICLE | Company News
Millennium licenses Targeted Diagnostics target
November 26, 2001 8:00 AM UTC
Targeted Diagnostics and Therapeutics (West Chester, Penn.) granted MLNM an exclusive worldwide license to its guanylyl cyclase C (GC-C), a protein expressed on colorectal tumors, and its related ente...